Airdate: Tuesday, September 26, 2023  Season: 10  Episode: 21

Guest: Víctor Andrés Arrieta


Dr. Víctor Andrés Arrieta from the Department of Neurosurgery at Northwestern University Feinberg School of Medicine answers questions from a recent webinar discussing the relationship between p-ERK activation and enhanced survival outcomes in rGBM patients undergoing anti-PD-1 immunotherapy.

Associated Webinar: Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in Forecasting Survival and Response to Immune Checkpoint Blockade in Glioblastoma Treatment

You can listen to this podcast on:

Similar Podcasts

Related Content